Search Site:      

   Site Map

  Contact Us   

   
Unraveling Brain Tumors - Molecular Biologists Devise Strategy To Starve Brain Tumors
  

July 24, 2008 (Science Daily) Brain tumor researchers have found that brain tumors arise from cancer stem cells living within tiny protective areas formed by blood vessels in the brain. Killing those cells is a promising strategy to eliminate tumors and prevents them from re-growing. The researchers have found that drugs that block new blood vessel formation can destroy the protected areas and stop cancer from developing.
More...
Hormone Therapy Not Shown to Benefit Older Patients with Early Prostate Cancer
  

July 16, 2008 (American Cancer Society) A study of nearly 20,000 men aged 66 and older with early-stage prostate cancer found that those who were prescribed androgen deprivation hormone therapy instead of other treatments were no better off than their counterparts who adopted a "wait and see" approach. However, younger men who aren't good candidates for surgery or radiation should still consider the therapy, which reduces androgen levels and often makes prostate cancers shrink or grow more slowly.
More...
A Threat in a Grassy Stroll: Lyme Disease

July 15, 2008 (The New York Times) My friend Anne and her husband, Richard, spend summers at a resort in Westchester County that has a swimming lake, tennis courts, gardens and beautiful grounds surrounded by woods. But Anne never sets foot on the grass.
More...
More News
Affinity Groups
Newsletter Printable Version E-Mail a Friend

MediGuide offers membership plans for Second Opinion services to affinity groups associated with banks, unions, and professional societies. Our current clients include three of the largest banks in North America, which offer MediGuide membership to their credit card holders. Affinity groups benefit from offering MediGuide membership through the increased member or customer satisfaction and loyalty.

Our marketing studies demonstrated that MediGuide concept is considered appealing by bank customers, with one-third to one-half of cardholders indicating that they find concept extremely appealing. The membership may be offered as a value-added benefit to select (for example, "gold" or "platinum" cardholders) at no additional charge for a cardholder, or as a voluntary add-on, in which case, cardholder is entitled to a significant discount from a regular MediGuide rate. When offered no-charge membership, majority of cardholders found the service very appealing.